MSB 3.21% $1.13 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-1581

  1. 647 Posts.
    lightbulb Created with Sketch. 319
    fda has already clearly indicated the pathway to an eua. and that was another trial which together with existing results "may" support an eua.
    in terms of your suggested massive buying monday based on new variant, i think we would only see some buying if we already had a trial running with near term prospects ot approval.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.